Viewing Study NCT04401995


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-02-10 @ 10:57 AM
Study NCT ID: NCT04401995
Status: COMPLETED
Last Update Posted: 2024-10-21
First Post: 2020-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination with Nivolumab Vs. Nivolumab
Sponsor: Diwakar Davar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None residual volume of tumor (RVT) View
None standard uptake value (SUV) View